In connection with the implementation of the project entitled ‘Design and development of nanoparticle-RNA based drugs to be used in anti-cancer therapy with the construction of a nanoparticle platform for targeted delivery of therapeutic nucleic acids’ by BS Biotechna SA, under agreement no. 2022/ABM/06/ 00005-00 for co-financing of a commercial project under the Competition for the development of targeted or personalised medicine based on medicinal products based on nucleic acids and small molecule compounds, the Contracting Authority is conducting market research on the costs of purchasing reagents.
In order to submit an offer, please read the detailed content of the announcement in the request for quotatoion 166/2024 and send us the completed offer form.